Cilcare featured in NewScientist !

New Scientist

In a groundbreaking article by Clare Wilson on NewScientist, a new understanding on tinnitus and deafness emerges, promising potential breakthroughs in treatment.

Tinnitus, characterized by persistent ringing or buzzing in the ears, affects millions worldwide, often with no clear cure. Deafness, similarly challenging to address, can profoundly impact one’s quality of life. However, recent findings challenge the conventional wisdom surrounding these conditions, and suggest they might not be as irreversible as once thought.

Wilson’s article delves into the latest research, revealing promising insights into the underlying mechanisms of tinnitus and deafness. Notably, the article highlights the significant contribution of Cilcare in this field. Cilcare is pioneering the development of several drugs that trigger the production of multiple neurotrophins, essential for auditory health.

The implications of this research are profound, offering hope to those who have long struggled with tinnitus and deafness. While further studies and clinical trials are needed to validate these findings, the potential for transformative treatments is undeniable.

Stay tuned as Cilcare continue to drive progress in this field !

Link to the article (for subscribers):

Share the Post: